Predilife Total Liabilities
Predilife total liabilities. Based on the latest financial reports, Predilife (ALPRE) has total liabilities worth €7.12 Million EUR (≈ $8.33 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ALPRE asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Predilife (2016–2024)
Total liabilities of Predilife from 2016 to 2024. This chart illustrates how Predilife's total liabilities have evolved over time, based on quarterly financial data.
Predilife Competitors by Total Liabilities
The table below lists competitors of Predilife ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Indosterling Technomedia Tbk
JK:TECH
|
Indonesia | Rp9.60 Billion |
|
Emergent Metals Corp
V:EMR
|
Canada | CA$1.51 Million |
|
Digitalist Group Oyj
HE:DIGIGR
|
Finland | €54.59 Million |
|
Capstone Holding Corp. Common Stock
NASDAQ:CAPS
|
USA | $42.26 Million |
|
Papyrus Australia Ltd
AU:PPY
|
Australia | AU$1.38 Million |
|
Addex Therapeutics Ltd
NASDAQ:ADXN
|
USA | $1.47 Million |
|
Quest PharmaTech Inc
V:QPT
|
Canada | CA$1.25 Million |
|
Pensionbee Group PLC
LSE:PBEE
|
UK | GBX5.54 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Predilife's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Predilife asset portfolio.
Liquidity & Leverage Metrics
Predilife Total Liabilities Ratios Explained
Predilife total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.08 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 5.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Predilife's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Predilife (2016–2024)
The table below shows the annual total liabilities of Predilife from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €6.71 Million ≈ $7.85 Million |
-19.18% |
| 2023-12-31 | €8.30 Million ≈ $9.71 Million |
-16.67% |
| 2022-12-31 | €9.97 Million ≈ $11.65 Million |
+80.21% |
| 2021-12-31 | €5.53 Million ≈ $6.47 Million |
+63.87% |
| 2020-12-31 | €3.37 Million ≈ $3.95 Million |
+59.64% |
| 2019-12-31 | €2.11 Million ≈ $2.47 Million |
-8.80% |
| 2018-12-31 | €2.32 Million ≈ $2.71 Million |
+0.76% |
| 2017-12-31 | €2.30 Million ≈ $2.69 Million |
+8.86% |
| 2016-12-31 | €2.11 Million ≈ $2.47 Million |
-- |
About Predilife
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer pred… Read more